Using a decision analysis, researchers led by Kaleb Michaud, PhD, at the University of Nebraska Medical Center, Omaha, determined that enhanced control of disease activity from treatment refinements based on results from the MBDA test resulted in an improvement in Health Assessment Questionnaire (HAQ) scores and cost savings over 10 years.

Click Here to read more